Crizotinib Resistance in ALK-Positive Lung Cancer

February 27, 2014

Special Reports, NSCLC (Issue 2), Volume 2, Issue 1

Alice T. Shaw, MD, PhD, an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital, discusses resistance to crizotinib in patients with ALK-positive lung cancer

Alice T. Shaw, MD, PhD, an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital, discusses resistance to crizotinib in patients with ALK-positive lung cancer.

Learn more about thetreatment of ALK-positive lung cancer > >